BAFNA PHARMACEUTICALS LIMITED

Other languages Bafna Pharmaceuticals Limited Bombay S.E.

Equities

BAFNAPH

INE878I01022

Market Closed - Bombay S.E. Other stock markets 03:30:52 16/07/2024 pm IST			5-day change	1st Jan Change
86 ^INR	-2.60%		+0.53%	-8.34%

29/06	Bafna Pharmaceuticals Limited Announces Temporary Disruption of Operations At Manufacturing Facility Situated At Grantlyon, Chennai	CI
29/05	Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bafna Pharmaceuticals Limited Announces Temporary Disruption of Operations At Manufacturing Facility Situated At Grantlyon, Chennai	29/06
Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory	26/04
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	23/04
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Bafna Pharmaceuticals Limited Announces Commercial Production	08/12
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone	07/12
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board	23/23/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11
Bafna Pharmaceuticals Limited Approves Board Appointment	27/23/27
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/23/27
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	07/23/07
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/23/08
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director	19/23/19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer